Skip to main content

Genetically engineered goats could be the key to mass-producing cancer drugs

Could the answer to mass-producing cancer drugs be … genetically modified goats? It might sound kind of crazy, but upon closer inspection, it actually makes a whole lot of sense. The drugs in question, therapeutic mAbs (aka monoclonal antibodies), are used in the treatment of human diseases including cancer. They are commonly produced in large bioreactors using cultured cells from mammals. But this process is extremely expensive, which in turn raises the cost for customers who may desperately need the drugs.

An international team of researchers led by Goetz Laible, a a senior scientist for New Zealand-based AgResearch and an animal scientist at the University of Auckland, is setting out to make these drugs in a different way — by using genetically engineered goats to produce them in their milk.

Related Videos

“To generate goats that are capable of producing the mAb in their milk, we first introduced the genes holding the information for the mAb into the genome of goat cells,” Laible told Digital Trends. “From such goat cells, live goats were generated using the cloning technology that was developed to generate the sheep Dolly. With these additional genes in their genomes, the goats were able to produce the antibody in their milk — but were otherwise normal, healthy animals.”

Goetz and his goats. Goetz Laible

This is not the first time that genetically engineered goats have been used as unlikely manufacturing vessels in the name of science. In 2012, scientists tested the idea of using goats for the production of spider silk in large quantities.

Laible said that this latest study validates the idea that goats could serve as an “excellent platform” for large-scale production of cancer-treatment drugs at a lower cost. In the process, it could help make the drugs, which are used for the treatment of a wide range of human diseases, available more widely. It may also have additional benefits.

“The scale of production is essentially fixed [at present due to ] the size of the bioreactor for mammalian cell cultures, and scaling of production volumes is very limited,” he said. “By contrast, an animal production platform is very flexible. Production volumes can be readily scaled by simply increasing or decreasing the number of production animals.”

The team now plans to undertake additional testing to further demonstrate the safety and effectiveness of anti-cancer treatments manufactured using goats.

A paper describing the research is available to read via the biology preprint server bioRxix.

Editors' Recommendations

Samsung Galaxy Watch 4 update focuses on holistic wellness
Woman wearing Galaxy Watch Active 2

Samsung Galaxy Watch 4 fans are getting a treat this week, with a new update that adds enhanced health and wellness features aimed at helping folks stay fit and reach all their goals.

This includes advanced interval training features for building custom workouts, a new sleep coaching program, and new insights for a better understanding of body composition.

Read more
Molekule adds an Air Score to its Air Pro purifier
molekule enables air score pro

Molekule, one of the leading manufacturers of air purifers, has announced a new feature for its Air Pro purifiers. This new feature, called the Molekule Air Score, provides an easy-to-understand air quality score that shows users the levels of particles and chemicals in the surrounding air.

Molekule states that the score is combined with one of their new sensors in the Air Pro purifiers. That sensor can capture nearby VOCs (volatile organic compounds like aerosol sprays or preservatives), humidity, and CO2 levels. Then, the sensor uses the data from the air to improve the device's 'Auto Protect' mode, which is what the Air Pro uses to adjust fan speeds automatically.

Read more
Snapchat finally adds safeguards against drug sales to minors
snapchat ios App Store. Credit: XanderXT / Shutterstock

Snapchat, TikTok, and other major tech companies were grilled late last year by the U.S. Congress for what was deemed as their half-hearted safety measures and algorithms to protect children from illicit drug deals, pornography exposure, and other potential problems. Now, Snapchat has taken a major step to ensure user safety by launching a Quick Add feature to protect minors between the ages of 13 to 17 from harassment and drug usage.
Safer friends 
Quick Add is essentially a friend suggestion feature that allows a user to add friends faster rather than searching for them via their usernames. A user shows up in another person's Quick Add list only if they have mutual friends or connections. For users younger than 18, in order to be discoverable in Quick Add, the underage user will need to have a certain number of mutual connections with the stranger to be allowed to add them to their network.  
Snapchat's protective features could ensure that other tech companies follow suit. XanderSt / Shutterstock
Identifying bad actors
During the congressional hearing last October, it was revealed that two youngsters in Minnesota died after consuming pills purchased from dealers they met on Snapchat. Unbeknownst to them, the prescription painkillers were laced with fentanyl, which can be an extremely dangerous drug. 
To counter this, Snapchat has put measures in place to identify drug slang and will also report potential cases to law enforcement. The company has also added the Community Anti-Drug Coalitions of America (CADCA) and Truth Initiative to its Heads Up portal to counter illegal drug usage. The platform claims that its updated A.I. algorithms can identify illegal accounts with more success, and even ban these users from creating new accounts.
Apps such as Instagram have also been called out over suggesting drugs to minors and for loopholes in profile restrictions for minors. 

Read more